331 related articles for article (PubMed ID: 27115953)
1. Therapeutic Approaches to Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Chronic Bronchitis.
Solomon GM; Raju SV; Dransfield MT; Rowe SM
Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2(Suppl 2):S169-76. PubMed ID: 27115953
[TBL] [Abstract][Full Text] [Related]
2. Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Chronic Bronchitis and Other Diseases of Mucus Clearance.
Raju SV; Solomon GM; Dransfield MT; Rowe SM
Clin Chest Med; 2016 Mar; 37(1):147-58. PubMed ID: 26857776
[TBL] [Abstract][Full Text] [Related]
3. The therapeutic potential of CFTR modulators for COPD and other airway diseases.
Solomon GM; Fu L; Rowe SM; Collawn JF
Curr Opin Pharmacol; 2017 Jun; 34():132-139. PubMed ID: 29132121
[TBL] [Abstract][Full Text] [Related]
4. Cystic Fibrosis Transmembrane Conductance Regulator. Implications in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.
Cantin AM
Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S150-5. PubMed ID: 27115950
[TBL] [Abstract][Full Text] [Related]
5. Hydrator Therapies for Chronic Bronchitis. Lessons from Cystic Fibrosis.
Bennett WD; Henderson AG; Donaldson SH
Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2(Suppl 2):S186-90. PubMed ID: 27115955
[TBL] [Abstract][Full Text] [Related]
6. The Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor Augments Mucociliary Clearance Abrogating Cystic Fibrosis Transmembrane Conductance Regulator Inhibition by Cigarette Smoke.
Raju SV; Lin VY; Liu L; McNicholas CM; Karki S; Sloane PA; Tang L; Jackson PL; Wang W; Wilson L; Macon KJ; Mazur M; Kappes JC; DeLucas LJ; Barnes S; Kirk K; Tearney GJ; Rowe SM
Am J Respir Cell Mol Biol; 2017 Jan; 56(1):99-108. PubMed ID: 27585394
[TBL] [Abstract][Full Text] [Related]
7. Cigarette smoke-induced Ca2+ release leads to cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction.
Rasmussen JE; Sheridan JT; Polk W; Davies CM; Tarran R
J Biol Chem; 2014 Mar; 289(11):7671-81. PubMed ID: 24448802
[TBL] [Abstract][Full Text] [Related]
8. CFTR dysfunction in cystic fibrosis and chronic obstructive pulmonary disease.
Fernandez Fernandez E; De Santi C; De Rose V; Greene CM
Expert Rev Respir Med; 2018 Jun; 12(6):483-492. PubMed ID: 29750581
[TBL] [Abstract][Full Text] [Related]
9. Cigarette Smoke-Induced Acquired Dysfunction of Cystic Fibrosis Transmembrane Conductance Regulator in the Pathogenesis of Chronic Obstructive Pulmonary Disease.
Shi J; Li H; Yuan C; Luo M; Wei J; Liu X
Oxid Med Cell Longev; 2018; 2018():6567578. PubMed ID: 29849907
[TBL] [Abstract][Full Text] [Related]
10. Vaporized E-Cigarette Liquids Induce Ion Transport Dysfunction in Airway Epithelia.
Lin VY; Fain MD; Jackson PL; Berryhill TF; Wilson LS; Mazur M; Barnes SJ; Blalock JE; Raju SV; Rowe SM
Am J Respir Cell Mol Biol; 2019 Aug; 61(2):162-173. PubMed ID: 30576219
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a novel CFTR potentiator in COPD ferrets with acquired CFTR dysfunction.
Kaza N; Lin VY; Stanford D; Hussain SS; Falk Libby E; Kim H; Borgonovi M; Conrath K; Mutyam V; Byzek SA; Tang LP; Trombley JE; Rasmussen L; Schoeb T; Leung HM; Tearney GJ; Raju SV; Rowe SM
Eur Respir J; 2022 Jul; 60(1):. PubMed ID: 34916262
[TBL] [Abstract][Full Text] [Related]
12. Potential systemic effects of acquired CFTR dysfunction in COPD.
Miravitlles M; Criner GJ; Mall MA; Rowe SM; Vogelmeier CF; Hederer B; Schoenberger M; Altman P
Respir Med; 2024 Jan; 221():107499. PubMed ID: 38104786
[TBL] [Abstract][Full Text] [Related]
13. Cigarette smoke and CFTR: implications in the pathogenesis of COPD.
Rab A; Rowe SM; Raju SV; Bebok Z; Matalon S; Collawn JF
Am J Physiol Lung Cell Mol Physiol; 2013 Oct; 305(8):L530-41. PubMed ID: 23934925
[TBL] [Abstract][Full Text] [Related]
14. CFTR targeted therapies: recent advances in cystic fibrosis and possibilities in other diseases of the airways.
Patel SD; Bono TR; Rowe SM; Solomon GM
Eur Respir Rev; 2020 Jun; 29(156):. PubMed ID: 32554756
[TBL] [Abstract][Full Text] [Related]
15. Unplugging Mucus in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.
Mall MA
Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S177-85. PubMed ID: 27115954
[TBL] [Abstract][Full Text] [Related]
16. Acquired Cystic Fibrosis Transmembrane Conductance Regulator Deficiency.
Cho DY; Woodworth BA
Adv Otorhinolaryngol; 2016; 79():78-85. PubMed ID: 27466849
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of S-Nitrosoglutathione Controls Cigarette Smoke-Induced Inflammatory-Oxidative Stress and Chronic Obstructive Pulmonary Disease-Emphysema Pathogenesis by Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function.
Bodas M; Silverberg D; Walworth K; Brucia K; Vij N
Antioxid Redox Signal; 2017 Sep; 27(7):433-451. PubMed ID: 28006950
[TBL] [Abstract][Full Text] [Related]
18. Cigarette smoke exposure induces CFTR internalization and insolubility, leading to airway surface liquid dehydration.
Clunes LA; Davies CM; Coakley RD; Aleksandrov AA; Henderson AG; Zeman KL; Worthington EN; Gentzsch M; Kreda SM; Cholon D; Bennett WD; Riordan JR; Boucher RC; Tarran R
FASEB J; 2012 Feb; 26(2):533-45. PubMed ID: 21990373
[TBL] [Abstract][Full Text] [Related]
19. Cystic Fibrosis Transmembrane Conductance Regulator: Roles in Chronic Obstructive Pulmonary Disease.
Dransfield M; Rowe S; Vogelmeier CF; Wedzicha J; Criner GJ; Han MK; Martinez FJ; Calverley P
Am J Respir Crit Care Med; 2022 Mar; 205(6):631-640. PubMed ID: 34982651
[TBL] [Abstract][Full Text] [Related]
20. Cystic fibrosis transmembrane conductance regulator function is suppressed in cigarette smokers.
Cantin AM; Hanrahan JW; Bilodeau G; Ellis L; Dupuis A; Liao J; Zielenski J; Durie P
Am J Respir Crit Care Med; 2006 May; 173(10):1139-44. PubMed ID: 16497995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]